Lastly, Polak et al. reported complete concordance between the increase in WT1 expression and MRD positivity verified with alternative methods (MFC and chimerism or specific markers if available) in 32 AML patients after Allo-SCT. The gene discussed is WT1; the disease is acute myeloid leukemia.